CoChat

Regional, age and sex differences in baseline characteristics of patients enrolled in the Trial Evaluating Cardiovascular Outcomes with Sitagliptin ( TECOS )

Bethel, M. A., Green, J. B., Milton, J., Tajar, A., Engel, S. S., Califf, R. M., Holman, R. R., on behalf of the TECOS Executive Committee · 2015 · Diabetes, Obesity and Metabolism
Cited by 46

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

Abstract

Aims: To report baseline characteristics and cardiovascular ( CV ) risk management by region, age, sex and CV event type for 14 724 participants in the T rial E valuating C ardiovascular O utcomes with S itagliptin ( TECOS ), a randomized, double‐blind, placebo‐controlled trial exploring whether sitagliptin added to usual type 2 diabetes ( T2DM ) care affects time to first event in the composite endpoint of CV death, non‐fatal myocardial infarction ( MI ), non‐fatal stroke or unstable angina hospitalization. Methods: TECOS enrolled patients aged ≥50 years, with T2DM and CV disease from 38 countries in five regions: N orth A merica, E astern E urope, W estern E urope, A sia P acific and L atin A merica. Participants had a glycated haemoglobin concentration of 6.5–8.0% (48–64 mmol/mol) and were receiving oral and/or insulin‐based antihyperglycaemic therapy. Analysis of variance or logistic regression was used to compare regional CV risk factors and treatments, referenced to N orth A merica. Results: Patients had a mean [1 standard deviation (SD)] age of 66 (8) years, a median (interquartile range) diabetes duration of 9.4 (4.9, 15.3) years, and a mean (SD) body mass index 30.2 (5.7) kg/m 2 . Compared with N orth A merica, blood pressure and lipids were higher in all regions. Statin use was lowest in L atin A merica (68%) and E astern E urope (70%) and aspirin use was lower compared with N orth A merica in all regions except A sia P acific. Achievement of treatment targets did not differ by age group or insulin usage, but men and participants with previous MI were more likely than women or those with previous stroke or peripheral arterial disease to reach most treatment goals. Conclusion: The CV risk factors of participants in TECOS are reasonably controlled, but differences in CV risk management according to region, sex and history of disease exist. This diversity will enhance the generalizability of the trial results.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/dom.12441

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 46

Metadata

Authors
Bethel, M. A., Green, J. B., Milton, J., Tajar, A., Engel, S. S., Califf, R. M., Holman, R. R., & on behalf of the TECOS Executive Committee
Venue
Diabetes, Obesity and Metabolism
Publisher
Wiley
Published
2015-02-13
Volume
17
Issue
4
Pages
395-402
ISSN
  • 1462-8902 (ISSN-L)
  • 1463-1326
OpenAlex
W2081225788
Cited by
46
References
10
FWCI
6.58
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.